期刊
JOURNAL OF IMMUNOLOGY
卷 194, 期 2, 页码 575-583出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1401085
关键词
-
类别
资金
- Interdisciplinary Center of Clinical Research at the University of Muenster Grant [Vo2/014/09]
- German Research Foundation [CRC 1009 B8, B9, Sonderforschungsbereich 704]
- Federal Ministry of Education and Research Project AID-NET
- German Research Foundation (Excellence Cluster ImmunoSensation)
- People Programme (Marie Curie Actions) of the European Union Research Executive Agency [317445]
The alarmins myeloid-related protein (MRP) 8 and MRP14 are the most prevalent cytoplasmic proteins in phagocytes. When released from activated or necrotic phagocytes, extracellular MRP8/MRP14 promote inflammation in many diseases, including infections, allergies, autoimmune diseases, rheumatoid arthritis, and inflammatory bowel disease. The involvement of TLR4 and the multiligand receptor for advanced glycation end products as receptors during MRP8-mediated effects on inflammation remains controversial. By comparative bioinformatic analysis of genome-wide response patterns of human monocytes to MRP8, endotoxins, and various cytokines, we have developed a model in which TLR4 is the dominant receptor for MRP8-mediated phagocyte activation. The relevance of the TLR4 signaling pathway was experimentally validated using human and murine models of TLR4- and receptor for advanced glycation end products-dependent signaling. Furthermore, our systems biology approach has uncovered an antiapoptotic role for MRP8 in monocytes, which was corroborated by independent functional experiments. Our data confirm the primary importance of the TLR4/MRP8 axis in the activation of human monocytes, representing a novel and attractive target for modulation of the overwhelming innate immune response.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据